4//SEC Filing
Kang JeenJoo 4
Accession 0001209191-21-049759
CIK 0001858848other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 6:30 PM ET
Size
7.1 KB
Accession
0001209191-21-049759
Insider Transaction Report
Form 4
Kang JeenJoo
Director
Transactions
- Conversion
Common Stock
2021-08-03+12,500→ 25,000 total - Conversion
Series A Preferred Stock
2021-08-03−12,500→ 0 totalExercise: $0.00→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]Each share of Series A Preferred Stock automatically converted into one share of common stock immediately prior to the completion of the Issuer's initial public offering, and had no expiration date.
Documents
Issuer
Tenaya Therapeutics, Inc.
CIK 0001858848
Entity typeother
Related Parties
1- filerCIK 0001868500
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 6:30 PM ET
- Size
- 7.1 KB